Wasatch Advisors Inc Adaptive Biotechnologies Corp Transaction History

Wasatch Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$24.56 - $32.8 $1.23 Million - $1.64 Million	-49,988 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $15,518 - $27,397	-512 Reduced 1.01%	49,988 $1.55 Million
Q2 2019 Aug 07, 2019	BUY	$40.3 - $48.3 $2.04 Million - $2.44 Million	50,500 New	50,500 $0

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $631M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.